 CAMBRIDGE, Mass., Nov. 08, 2022 GLOBE NEWSWIRE -- Evelo Biosciences, Inc. Nasdaq: EVLO, a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on the small intestinal axis, SINTAX, today announced that Simba Gill, Ph.D., Chief Executive Officer of Evelo, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022, at 7:25 a.m. GMT. 